Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Licorice root extract mouthwash is an investigational herbal formulation developed by Cairo University for the prevention of dental caries, particularly in patients at high risk. The active component is an ethanol extract of *Glycyrrhiza glabra* (licorice root), which contains several bioactive polyphenols and saponins, including glycyrrhizin (glycyrrhizic acid), glabridin, licochalcone A, licoricidin, and licorisoflavan A. The primary mechanism of action involves the inhibition of glucosyltransferase (GTF) enzymes, which are essential for the synthesis of extracellular polysaccharides by *Streptococcus mutans*. By blocking these enzymes, the extract prevents the formation of dental biofilms (plaque), thereby reducing the incidence of caries. The formulation is being evaluated in Phase 2/3 clinical trials (NCT03590977, NCT03684993) as a natural alternative to traditional antimicrobial agents like chlorhexidine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on licorice root extract mouthwash.